_id

690dae8eccc777a4e85d0a98

Ticker

AMRN

Name

Amarin Corporation PLC

Exchange

NASDAQ

Address

One Central Plaza, Dublin, Ireland, D02 K7K5

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - General

Currency

USD

Website

https://www.amarincorp.com

Description

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

Last Close

14.48

Volume

101735

Current Price

14.36

Change

-0.8287292817679627

Last Updated

2025-11-28T12:12:42.723Z

Image

-

Ipo Date

1993-04-01T00:00:00.000Z

Market Cap

335593920

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.34242857142857147

Sentiment Sources

7

Rating

2.3333

Target Price

12

Strong Buy

0

Buy

0

Hold

1

Sell

2

Strong Sell

0

Current Quarter

2025-09-30

Revenue

48558000

Cost Of Revenue

26350000

Gross Profit

22208000

Operating Expenses

23905000

Operating Income

-1697000

Interest Expense

-

Pretax Income

-7361000

Net Income

-7738000

Eps

-0.018621956003282546

Dividends Per Share

-

Shares Outstanding

20792684

Income Tax Expense

377000

EBITDA

-6494000

Operating Margin

-3.4947897359858313

Total Other Income Expense Net

-5664000

Cash

122802000

Short Term Investments

163785000

Receivables

127309000

Inventories

184703000

Total Current Assets

628334000

Property Plant Equipment

7199000

Total Assets

659814000

Payables

36712000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

200920000

Equity

458894000

Depreciation

861793

Change In Working Capital

-7098615

Cash From Operations

-12763444

Capital Expenditures

4.89

Cash From Investing

-12294898

Cash From Financing

-239995

Net Change In Cash

-25074000

PE

-

PB

13.00305769959947

ROE

-1.6862281921315163

ROA

-1.1727547460344885

FCF

-12763448.89

Fcf Percent

-0.26284955908398205

Piotroski FScore

0

Health Score

26

Deep Value Investing Score

4

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

3.5

Net Net Investing Score

5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

48558000

Quarters > 0 > income Statement > cost Of Revenue

26350000

Quarters > 0 > income Statement > gross Profit

22208000

Quarters > 0 > income Statement > operating Expenses

23905000

Quarters > 0 > income Statement > operating Income

-1697000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-7361000

Quarters > 0 > income Statement > net Income

-7738000

Quarters > 0 > income Statement > eps

-0.018621956003282546

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

415531000

Quarters > 0 > income Statement > income Tax Expense

377000

Quarters > 0 > income Statement > EBITDA

-6494000

Quarters > 0 > income Statement > operating Margin

-3.4947897359858313

Quarters > 0 > income Statement > total Other Income Expense Net

-5664000

Quarters > 0 > balance Sheet > cash

122802000

Quarters > 0 > balance Sheet > short Term Investments

163785000

Quarters > 0 > balance Sheet > receivables

127309000

Quarters > 0 > balance Sheet > inventories

184703000

Quarters > 0 > balance Sheet > total Current Assets

628334000

Quarters > 0 > balance Sheet > property Plant Equipment

7199000

Quarters > 0 > balance Sheet > total Assets

659814000

Quarters > 0 > balance Sheet > payables

36712000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

200920000

Quarters > 0 > balance Sheet > equity

458894000

Quarters > 0 > cash Flow > net Income

-7691529

Quarters > 0 > cash Flow > depreciation

861793

Quarters > 0 > cash Flow > change In Working Capital

-7098615

Quarters > 0 > cash Flow > cash From Operations

-12763444

Quarters > 0 > cash Flow > capital Expenditures

4.89

Quarters > 0 > cash Flow > cash From Investing

-12294898

Quarters > 0 > cash Flow > cash From Financing

-239995

Quarters > 0 > cash Flow > net Change In Cash

-25074000

Quarters > 0 > ratios > PE

-0.018621956003282546

Quarters > 0 > ratios > PB

13.00305769959947

Quarters > 0 > ratios > ROE

-1.6862281921315163

Quarters > 0 > ratios > ROA

-1.1727547460344885

Quarters > 0 > ratios > FCF

-12763448.89

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-0.26284955908398205

Quarters > 0 > health Score

26

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

72741000

Quarters > 1 > income Statement > cost Of Revenue

22379000

Quarters > 1 > income Statement > gross Profit

50362000

Quarters > 1 > income Statement > operating Expenses

66347000

Quarters > 1 > income Statement > operating Income

-15985000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-13450000

Quarters > 1 > income Statement > net Income

-14139000

Quarters > 1 > income Statement > eps

-0.03411286995418322

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

414477000

Quarters > 1 > income Statement > income Tax Expense

689000

Quarters > 1 > income Statement > EBITDA

7503000

Quarters > 1 > income Statement > operating Margin

-21.975227175870554

Quarters > 1 > income Statement > total Other Income Expense Net

2535000

Quarters > 1 > balance Sheet > cash

147877000

Quarters > 1 > balance Sheet > short Term Investments

150827000

Quarters > 1 > balance Sheet > receivables

119130000

Quarters > 1 > balance Sheet > inventories

171244000

Quarters > 1 > balance Sheet > total Current Assets

606819000

Quarters > 1 > balance Sheet > property Plant Equipment

7654000

Quarters > 1 > balance Sheet > total Assets

670126000

Quarters > 1 > balance Sheet > payables

44711000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

205202000

Quarters > 1 > balance Sheet > equity

464924000

Quarters > 1 > cash Flow > net Income

-14139000

Quarters > 1 > cash Flow > depreciation

729000

Quarters > 1 > cash Flow > change In Working Capital

24950000

Quarters > 1 > cash Flow > cash From Operations

16606000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

12410000

Quarters > 1 > cash Flow > cash From Financing

-663000

Quarters > 1 > cash Flow > net Change In Cash

28353000

Quarters > 1 > ratios > PE

-0.03411286995418322

Quarters > 1 > ratios > PB

12.801855184933451

Quarters > 1 > ratios > ROE

-3.041142208188865

Quarters > 1 > ratios > ROA

-2.1099017199750496

Quarters > 1 > ratios > FCF

16606000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

0.22828941037379194

Quarters > 1 > health Score

46

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

42017000

Quarters > 2 > income Statement > cost Of Revenue

16887000

Quarters > 2 > income Statement > gross Profit

25130000

Quarters > 2 > income Statement > operating Expenses

41885000

Quarters > 2 > income Statement > operating Income

-16755000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-13630000

Quarters > 2 > income Statement > net Income

-15697000

Quarters > 2 > income Statement > eps

-0.03803424705662855

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

412707000

Quarters > 2 > income Statement > income Tax Expense

2067000

Quarters > 2 > income Statement > EBITDA

-16025000

Quarters > 2 > income Statement > operating Margin

-39.87671656710379

Quarters > 2 > income Statement > total Other Income Expense Net

3125000

Quarters > 2 > balance Sheet > cash

119524000

Quarters > 2 > balance Sheet > short Term Investments

162263000

Quarters > 2 > balance Sheet > receivables

106734000

Quarters > 2 > balance Sheet > inventories

159490000

Quarters > 2 > balance Sheet > total Current Assets

573061000

Quarters > 2 > balance Sheet > property Plant Equipment

8378000

Quarters > 2 > balance Sheet > total Assets

655677000

Quarters > 2 > balance Sheet > payables

45661000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

181990000

Quarters > 2 > balance Sheet > equity

473687000

Quarters > 2 > cash Flow > net Income

-15697000

Quarters > 2 > cash Flow > depreciation

730000

Quarters > 2 > cash Flow > change In Working Capital

-603000

Quarters > 2 > cash Flow > cash From Operations

-12459000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

12064000

Quarters > 2 > cash Flow > cash From Financing

-1119000

Quarters > 2 > cash Flow > net Change In Cash

-1514000

Quarters > 2 > ratios > PE

-0.03803424705662855

Quarters > 2 > ratios > PB

12.51136830860885

Quarters > 2 > ratios > ROE

-3.313791596560598

Quarters > 2 > ratios > ROA

-2.394014125857701

Quarters > 2 > ratios > FCF

-12459000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.29652283599495444

Quarters > 2 > health Score

27

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

62306000

Quarters > 3 > income Statement > cost Of Revenue

71873000

Quarters > 3 > income Statement > gross Profit

-9567000

Quarters > 3 > income Statement > operating Expenses

42955000

Quarters > 3 > income Statement > operating Income

-52522000

Quarters > 3 > income Statement > interest Expense

7000

Quarters > 3 > income Statement > pretax Income

-49907000

Quarters > 3 > income Statement > net Income

-48618000

Quarters > 3 > income Statement > eps

-0.11831010592864599

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

410937000

Quarters > 3 > income Statement > income Tax Expense

-1289000

Quarters > 3 > income Statement > EBITDA

-37181000

Quarters > 3 > income Statement > operating Margin

-84.29685744551087

Quarters > 3 > income Statement > total Other Income Expense Net

2615000

Quarters > 3 > balance Sheet > cash

121038000

Quarters > 3 > balance Sheet > short Term Investments

173182000

Quarters > 3 > balance Sheet > receivables

122279000

Quarters > 3 > balance Sheet > inventories

166048000

Quarters > 3 > balance Sheet > total Current Assets

595399000

Quarters > 3 > balance Sheet > property Plant Equipment

7608000

Quarters > 3 > balance Sheet > total Assets

685349000

Quarters > 3 > balance Sheet > payables

40366000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

199173000

Quarters > 3 > balance Sheet > equity

486176000

Quarters > 3 > cash Flow > net Income

-48167207

Quarters > 3 > cash Flow > depreciation

730166

Quarters > 3 > cash Flow > change In Working Capital

32734763

Quarters > 3 > cash Flow > cash From Operations

-13243446

Quarters > 3 > cash Flow > capital Expenditures

3.44

Quarters > 3 > cash Flow > cash From Investing

-22754345

Quarters > 3 > cash Flow > cash From Financing

22955

Quarters > 3 > cash Flow > net Change In Cash

-36132000

Quarters > 3 > ratios > PE

-0.11831010592864599

Quarters > 3 > ratios > PB

12.137693592443888

Quarters > 3 > ratios > ROE

-10.000082274731785

Quarters > 3 > ratios > ROA

-7.093903981766954

Quarters > 3 > ratios > FCF

-13243449.44

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.21255496164093346

Quarters > 3 > health Score

27

Valuation > metrics > PE

-0.018621956003282546

Valuation > metrics > PB

13.00305769959947

Valuation > final Score

20

Valuation > verdict

333.4% Overvalued

Profitability > metrics > ROE

-1.6862281921315163

Profitability > metrics > ROA

-1.2315106296969447

Profitability > metrics > Net Margin

-0.1593558219037028

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.43783531708847795

Risk > metrics > Interest Coverage

-1.9573241061130335

Risk > final Score

52

Risk > verdict

High

Liquidity > metrics > Current Ratio

17.115221181085204

Liquidity > metrics > Quick Ratio

12.084086947047288

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

57

Prev Risks > 1

32

Prev Risks > 2

-29953

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:13:31.172Z